“Keeping in mind the favorable effects of oxytocin on animal models of anxiety and depression, we postulated that synergy between prescribed first choice drugs, selective serotonin reuptake inhibitors SSRIs ) and oxytocin could improve the treatment outcome compared with SSRI monotherapy.”